The GOG Foundation, Inc.
GOG GYN-LIVE
Welcome to the official podcast of The GOG Foundation, Inc.—a nonprofit organization dedicated to advancing excellence in clinical and scientific research for gynecologic cancers. From ovarian and uterine to cervical, vaginal, and vulvar malignancies, our investigators and institutions are at the forefront of innovation, shaping the future of cancer care. Each episode features leading experts, groundbreaking trial insights, and real-world stories that illuminate the evolving landscape of gynecologic oncology. Whether you're a clinician, researcher, patient advocate, or survivor, join us as we...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Accrual Culture: Top Points for Site Selection - Timelines 02.04.2026 20:57
The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast: Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem ★ Support this podcast ★
GOG-3101 | TroFuse-20 Clinical Trial Update 05.03.2026 13:00
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer. ★ Support this podcast ★
The GOG Highlight Reel - January 2026 20.02.2026 2:15:51
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel” , an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensi...
Accrual Culture: Top Points for Site Selection - Enrollement 30.01.2026 18:21
The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process. ★ Support this podcast ★
GOG Highlight Reel - January 2025 16.10.2025 2:33:13
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel” , an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. A twice-yearly event, our most recent program took place Saturday, January 18, 2025, in Phoenix, Arizona alongside the 2025 NRG Oncology Winter Meeting. The GOG Hi...
The GOG Highlight Reel - July 2025 15.10.2025 2:28:59
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel” , an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year. This twice-yearly event was most recently held on Saturday, July 26, 2025, in Washington D.C. alongside the 2025 NRG Oncology Summer Meeting. The GOG Highlight Ree...
Accrual Culture: The Four Components of A Successful Clinical Trial Network 09.10.2025 11:17
The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process. ★ Support this podcast ★
Similar podcasts
Listen to the GOG GYN-LIVE podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
